NR 565 - advanced pharmacology midterm – Chamberlain NEWEST TEST EXAM 100 COMPREHENSIVE QUESTIONS /FREQUENTLY MOST TES

This document provides a comprehensive overview of the NR 565 Advanced Pharmacology midterm exam from Chamberlain, dated 25 September 2026. It includes 100 thoroughly vetted questions that are frequently tested in the field of advanced pharmacology. The questions cover a wide range of topics crucial for students aiming to excel in pharmacology.

Key areas include the functions of naloxone in patients on buprenorphine, with a focus on preventing toxicity and the limitations in reversing ongoing toxicity. The document also emphasizes the importance of caution when prescribing medications to the elderly due to risks like polypharmacy. Additionally, it provides guidelines on acetaminophen usage, noting misconceptions such as the daily limit of tablets.

The role of Prescription Drug Monitoring Programs (PDMPs) in identifying patients at risk for overdose is highlighted, alongside the significance of black box warnings in communicating drug risks. The document discusses side effects of various drug classes, such as reflex tachycardia associated with Calcium Channel Blockers, and identifies safe blood pressure medications for pregnant women, like Labetalol.

Furthermore, it details the effects of Ezetimibe on cholesterol levels, monitoring needs for thiazide diuretics, and the first-line treatment for African Americans as per CPG guidelines. The document also educates on the effects of digoxin on heart function, advising when to withhold the drug, and warns against the interaction between Amiodarone and grapefruit juice.

This exam preparation material is essential for students in advanced pharmacology, offering accurate solutions and insights into medication management and safety.